SCHEMBL21281966

SCHEMBL21281966

c1ccc(N(c2ccc3oc4cc(N(c5cccc6ccccc56)c5cccc6ccccc56)ccc4c3c2)c2cccc3c2oc2ccccc23)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DUSP3 P51452 1/20 0.34
MAPT P10636 6/20 0.34
KDM4E B2RXH2 6/20 0.34
HPGD P15428 5/20 0.34
ALDH1A1 P00352 5/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
NPC1 O15118 3/20 0.34
AHR P35869 2/20 0.34
RAB9A P51151 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GLA P06280 2/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GAA P10253 2/20 0.32
ALOX5 P09917 2/20 0.32
SIGMAR1 Q99720 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21966506 0.92 MAPT (0.38) MAPTKDM4EHPGDALDH1A1KMT2A
SCHEMBL21968724 0.92 KDM4E (0.38) DUSP3MAPTKDM4EHPGDALDH1A1
SCHEMBL22506123 0.92 MAPT (0.38) MAPTKDM4EHPGDALDH1A1KMT2A
SCHEMBL21966510 0.92 MAPT (0.38) MAPTKDM4EHPGDALDH1A1KMT2A
SCHEMBL21966511 0.91 KDM4E (0.37) DUSP3MAPTKDM4EHPGDALDH1A1
SCHEMBL24888044 0.90 KDM4E (0.37) MAPTKDM4EHPGDALDH1A1KMT2A
SCHEMBL17126348 0.89 KDM4E (0.41) DUSP3MAPTKDM4EHPGDALDH1A1
SCHEMBL15964368 0.89 MAPT (0.41) MAPTKDM4EHPGDALDH1A1KMT2A
SCHEMBL22506091 0.89 CYP1A1 (0.35) DUSP3MAPTKDM4EHPGDALDH1A1
SCHEMBL15851854 0.89 L3MBTL1 (0.39) DUSP3MAPTKDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210028370-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR DUK SAN NEOLUX CO., LTD. (KR) 2021-01-28 US disclosed
US-20200203623-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2020-06-25 US disclosed
EP-3670510-A2 BENZO[B]NAPHTHO[2,3-D]FURANYL- OR BENZO[B]NAPHTHO[2,3-D]THIOPHENYL-TRIAZINE COMPOUNDS FOR ORGANIC ELECTRONIC ELEMENTS Duk San Neolux Co., Ltd. (KR) 2020-06-24 EP disclosed
WO-2019190101-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR 덕산네오룩스 주식회사 2019-10-03 WO disclosed
WO-2019160335-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2019-08-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210028370-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR OR51E2, WEE1, SLC39A11 DUSP3 4833/4885MAPT 2705/4885KDM4E 1966/4885
US-20200203623-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF GPX1, PIEZO1, ORAI2 DUSP3 3551/4885MAPT 3035/4885KDM4E 2039/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.